How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cholecalciferol-vitamin-d3.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

cholecalciferol (vitamin D3) — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

cholecalciferol (vitamin D3) (cholecalciferol (vitamin D3)) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin D analog / Secosteroid. Area: Endocrinology / Bone Health / Immunology.

marketed Vitamin D analog / Secosteroid Vitamin D receptor (VDR) Endocrinology / Bone Health / Immunology Small molecule Live · refreshed every 30 min

Target snapshot

cholecalciferol (vitamin D3) (cholecalciferol (vitamin D3)) — Medical University of South Carolina. Cholecalciferol (vitamin D3) is converted in the body to its active form, calcitriol, which regulates calcium and phosphate homeostasis and modulates immune function.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
cholecalciferol (vitamin D3) TARGET	cholecalciferol (vitamin D3)	Medical University of South Carolina	marketed	Vitamin D analog / Secosteroid	Vitamin D receptor (VDR)
Vitamin D3 (High dose)	Vitamin D3 (High dose)	Shiraz University of Medical Sciences	phase 3	Vitamin D analog / Secosteroid	Vitamin D receptor (VDR)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin D analog / Secosteroid class)

Medical University of South Carolina · 1 drug in this class
Shiraz University of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). cholecalciferol (vitamin D3) — Competitive Intelligence Brief. https://druglandscape.com/ci/cholecalciferol-vitamin-d3. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab